Therefore, JSO ameliorates anxiety-like behaviors by upregulating BDNF expression, suppressing hyperactivation of the PI3K/AKT/mTOR signaling pathway, and reducing the BAX/BCL-2 ratio, thereby enhancing neuronal survival and synaptic plasticity. This evidence concerns the gene AKT1 and Joubert syndrome with ocular defect.